In the most recent trading session, Albemarle (ALB) closed at $67.21, indicating a -1.15% shift from the previous trading day.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Albemarle (ALB) concluded the recent trading session at $64.95, signifying a +1.88% move from its prior day's close.
![]() ALB In 2 months Estimated | Quarterly | $0.41 Per Share |
![]() ALB 3 weeks ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 3 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 6 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 9 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 14 Jun 2024 Paid | Quarterly | $0.4 Per Share |
30 Jul 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
30 Apr 2025 Date | | - Cons. EPS | - EPS |
12 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
![]() ALB In 2 months Estimated | Quarterly | $0.41 Per Share |
![]() ALB 3 weeks ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 3 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 6 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 9 months ago Paid | Quarterly | $0.41 Per Share |
![]() ALB 14 Jun 2024 Paid | Quarterly | $0.4 Per Share |
30 Jul 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
30 Apr 2025 Date | | - Cons. EPS | - EPS |
12 Feb 2025 Date | | - Cons. EPS | - EPS |
6 Nov 2024 Date | | - Cons. EPS | - EPS |
30 Oct 2024 Date | | - Cons. EPS | - EPS |
Chemicals - Specialty Industry | Basic Materials Sector | Jerry Kent Masters Jr. CEO | CXA Exchange | US0126531013 ISIN |
US Country | 8,300 Employees | 14 Mar 2025 Last Dividend | 2 Mar 2007 Last Split | 17 Feb 1994 IPO Date |
Albemarle Corporation is centered around the development, manufacturing, and marketing of specialty chemicals on a global scale. The company's operations are segmented into Energy Storage, Specialties, and Ketjen, catering to a wide array of industries including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Founded in 1887 and with its headquarters in Charlotte, North Carolina, Albemarle has established itself as a key player in the engineered specialty chemicals market.
This segment delivers lithium compounds like lithium carbonate, lithium hydroxide, and lithium chloride. It also provides technical services for the safe handling and usage of reactive lithium products, in addition to recycling services for lithium-containing by-products. These offerings play a crucial role in supporting the demanding energy storage market.
In this segment, Albemarle offers bromine-based specialty chemicals, including elemental bromine, various bromides, brominated powdered activated carbon, and other fine chemicals. It also features lithium specialties such as butyllithium and lithium aluminum hydride, and develops and manufactures cesium products for chemical and pharmaceutical applications. Furthermore, this segment provides zirconium, barium, and titanium products designed for use in pyrotechnical applications including airbag initiators, serving diverse markets from construction to pharmaceuticals.
Focused on clean fuels technologies (CFT), the Ketjen segment encompasses hydroprocessing catalysts (HPC) along with isomerization and akylation catalysts. It also provides fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS) which include organometallics and curatives. These products and technologies are vital for the petroleum refining industry, ensuring more efficient processing and higher-quality fuel production.